Skip to content

Drug prices are too high. What is Congress trying to do about it?

Chairman Charles E. Grassley, right, and ranking member Sen. Ron Wyden are seen before a Senate Finance Committee on drug pricing in America on February 26, 2019. (Tom Williams/CQ Roll Call)
Chairman Charles E. Grassley, right, and ranking member Sen. Ron Wyden are seen before a Senate Finance Committee on drug pricing in America on February 26, 2019. (Tom Williams/CQ Roll Call)

Both the House and the Senate have competing bills aimed at addressing the rising costs of prescription drugs, a legislative priority backed by President Donald Trump.

But what would these various proposals accomplish, and how likely is it they’ll be signed into law?

[jwp-video n=”1″]

Recent Stories

Race for Platner alternative takes shape

Trump: Definitely not signing bipartisan housing bill

Government-seeded accounts could test Trump’s ‘communists’ claim

After Thursday night firings, election commission has no members

CBO: House highway bill would widen trust fund deficit

As Trump threatens the Smithsonian, Congress is on the sidelines